2014 Q2/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +1 Cytogen
8.2
2 +77 Biogen Idec
7.9
3 +5 Taisho Pharmaceutical
7.2
4 -1 Kyowa Hakko Kirin UK
7.2
5 +1 Biotecnol
7.1
6 +9 Vectura
7.1
7 -2 Kyorin Holdings
7.0
8 -4 Galenica AG
6.9
9 +2 Kaken Pharmaceutical
6.7
10 +8 Otsuka Pharmaceuticals Europe
6.6
11 -2 EISAI UK
6.6
12 -2 Wockhardt
6.6
13 +0 Actelion UK
6.4
14 -7 Questcor
6.4
15 +2 Advaxis
6.3
16 +9 Otsuka Pharmaceuticals
6.2
17 -1 EISAI
6.0
18 +3 Meda Pharmaceuticals
5.8
19 -7 Yakult UK
5.8
20 +2 Genmab
5.7
21 +30 MorphoSys
5.7
22 -8 Servier UK
5.6
23 +1 Actelion
5.5
24 -4 Genzyme UK
5.4
25 +32 Debiopharm
5.3
26 +40 Nippon Chemiphar
5.3
27 +14 Covence
5.3
28 +5 Novartis UK
5.3
29 +0 Zandu
5.2
30 -1 Dainippon Sumitomo
5.2
31 +37 Anavex Life Sciences Corp
5.2
32 -1 QLT
5.2
33 -5 Recordati
5.1
34 -7 Valeant Pharmaceuticals
5.1
35 +20 KRKA
5.0
36 +8 Bavarian Nordic
5.0
37 -7 Dusa Pharmaceuticals
5.0
38 +21 Alkermes
4.9
39 +1 Laboratoires Thea
4.9
40 +6 Apotex
4.9
41 +110 Forest
4.9
42 +23 Kissei
4.9
43 +0 Boehringer Ingelheim
4.9
44 +8 Mylan
4.9
45 -11 Santen
4.8
46 +96 Therabel
4.8
47 +0 CSL Behring UK
4.8
48 +0 Stallergenes UK
4.8
49 -11 Sanofi UK
4.8
50 +0 Galderma
4.8


Changes in rank are compared to 2014 Q1/Global Life Sciences. Since then, 6 sites entered the survey, 1 site left the survey and 52 sites could not be included in the rankings (3 fewer since last time). Build your own. Report statistics.